Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02551185
Title ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acetylon Pharmaceuticals Incorporated
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Pinnacle Oncology Hematology Scottsdale Arizona 85258 United States Details
Remove - Emory University Winship Cancer Institute Atlanta Georgia 30322 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
CTRC at The UT Health Science Center at San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field